These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35647674)

  • 1. Application of exosomes for the alleviation of COVID-19-related pathologies.
    Rezabakhsh A; Mahdipour M; Nourazarian A; Habibollahi P; Sokullu E; Avci ÇB; Rahbarghazi R
    Cell Biochem Funct; 2022 Jul; 40(5):430-438. PubMed ID: 35647674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications, challenges and prospects of mesenchymal stem cell exosomes in regenerative medicine.
    Rezabakhsh A; Sokullu E; Rahbarghazi R
    Stem Cell Res Ther; 2021 Sep; 12(1):521. PubMed ID: 34583767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.
    Akbari A; Rezaie J
    Stem Cell Res Ther; 2020 Aug; 11(1):356. PubMed ID: 32795359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises.
    Rezakhani L; Kelishadrokhi AF; Soleimanizadeh A; Rahmati S
    Chem Phys Lipids; 2021 Jan; 234():105009. PubMed ID: 33189639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs.
    Jamshidi E; Babajani A; Soltani P; Niknejad H
    Stem Cell Rev Rep; 2021 Feb; 17(1):176-192. PubMed ID: 33432484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients.
    Raghav A; Khan ZA; Upadhayay VK; Tripathi P; Gautam KA; Mishra BK; Ahmad J; Jeong GB
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicles as a Translational Approach for the Treatment of COVID-19 Disease: An Updated Overview.
    Serretiello E; Ballini A; Smimmo A; Acunzo M; Raimo M; Cantore S; Di Domenico M
    Viruses; 2023 Sep; 15(10):. PubMed ID: 37896755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments.
    Gurunathan S; Kang MH; Kim JH
    Front Immunol; 2021; 12():716407. PubMed ID: 34394121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
    Cheng X; Jiang M; Long L; Meng J
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
    [No Abstract]   [Full Text] [Related]  

  • 10. The Role of Exosomes in the Treatment, Prevention, Diagnosis, and Pathogenesis of COVID-19.
    Zani-Ruttenstock E; Antounians L; Khalaj K; Figueira RL; Zani A
    Eur J Pediatr Surg; 2021 Aug; 31(4):326-334. PubMed ID: 34161984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19.
    Pinky ; Gupta S; Krishnakumar V; Sharma Y; Dinda AK; Mohanty S
    Stem Cell Rev Rep; 2021 Feb; 17(1):33-43. PubMed ID: 32661867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS.
    Grigoropoulos I; Tsioulos G; Kastrissianakis A; Shapira S; Green O; Rapti V; Tsakona M; Konstantinos T; Savva A; Kavatha D; Boumpas D; Syrigos K; Xynogalas I; Leontis K; Ntousopoulos V; Sakka V; Sardelis Z; Fotiadis A; Vlassi L; Kontogianni C; Levounets A; Poulakou G; Gaga M; MacLoughlin R; Stebbing J; Arber N; Antoniadou A; Tsiodras S
    Respir Res; 2024 Apr; 25(1):151. PubMed ID: 38561798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2.
    Wang Z; Hu S; Popowski KD; Liu S; Zhu D; Mei X; Li J; Hu Y; Dinh PC; Wang X; Cheng K
    Nat Commun; 2024 Mar; 15(1):2236. PubMed ID: 38472181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells and their derived exosomes to combat Covid-19.
    Yousefi Dehbidi M; Goodarzi N; Azhdari MH; Doroudian M
    Rev Med Virol; 2022 Mar; 32(2):e2281. PubMed ID: 34363275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell-based and mesenchymal stem cell derivatives for coronavirus treatment.
    Rafiee Z; Nejaddehbashi F; Nasrolahi A; Khademi Moghadam F
    Biotechnol Appl Biochem; 2022 Oct; 69(5):1942-1965. PubMed ID: 34555225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
    Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    Elife; 2020 Oct; 9():. PubMed ID: 33112236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
    Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
    BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosome-Based Multivalent Vaccine: Achieving Potent Immunization, Broadened Reactivity, and Strong T-Cell Responses with Nanograms of Proteins.
    Cacciottolo M; Nice JB; Li Y; LeClaire MJ; Twaddle R; Mora CL; Adachi SY; Chin ER; Young M; Angeles J; Elliott K; Sun M
    Microbiol Spectr; 2023 Jun; 11(3):e0050323. PubMed ID: 37093009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising use of immune cell-derived exosomes in the treatment of SARS-CoV-2 infections.
    Alahdal M; Elkord E
    Clin Transl Med; 2022 Aug; 12(8):e1026. PubMed ID: 35988156
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.